{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:42:03Z","timestamp":1747183323080,"version":"3.40.5"},"reference-count":3,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p><jats:bold>LINKED CONTENT<\/jats:bold><\/jats:p><jats:p>This article is linked to Lee et al and Lee and Kim papers. To view these articles, visit <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.1111\/apt.15741\">https:\/\/doi.org\/10.1111\/apt.15741<\/jats:ext-link> and <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.1111\/apt.16000\">https:\/\/doi.org\/10.1111\/apt.16000<\/jats:ext-link><\/jats:p>","DOI":"10.1111\/apt.15973","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T03:43:18Z","timestamp":1693885398000},"page":"1093-1093","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune tolerant phase"],"prefix":"10.1111","volume":"52","author":[{"given":"Bo","family":"Wan","sequence":"first","affiliation":[{"name":"Faculty of Life Sciences and Medicine King\u2019s College London London UK"},{"name":"Guy's and St Thomas' NHS Foundation Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0335-6550","authenticated-orcid":false,"given":"Ruanqin","family":"Chen","sequence":"additional","affiliation":[{"name":"Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Lin","sequence":"additional","affiliation":[{"name":"Fujian Medical University Union Hospital Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"e_1_2_1_4_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15741"},{"key":"e_1_2_1_4_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28917"},{"key":"e_1_2_1_4_4_1","article-title":"The impact of hepatitis B virus infection status on the prevalence of nonalcoholic fatty liver disease: a population\u2010based study","author":"Huang J","year":"2019","journal-title":"J Med Virol"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.15973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T03:44:15Z","timestamp":1693885455000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.15973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":3,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1111\/apt.15973"],"URL":"https:\/\/doi.org\/10.1111\/apt.15973","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"type":"print","value":"0269-2813"},{"type":"electronic","value":"1365-2036"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"assertion":[{"value":"2020-08-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}